Danish companies Novozymes and Novo Nordisk Pharmatech are teaming up to develop technical enzymes to support biopharma processing. The companies aim to develop high...
Danish pharma Novo Nordisk has agreed to buy Dicerna Pharmaceuticals, offering $3.3 billion for the US biopharma and its ribonucleic acid interference (RNAi) platform.
Danish drugmaker Novo Nordisk has acquired Prothena’s clinical-stage stage antibody PRX004 and broader ATTR amyloidosis program, gaining full global rights to the...
15.06.2020
- Danish drugmaker Novo Nordisk has agreed to buy Corvidia Therapeutics, a privately held, US-based clinical-stage company focused on the research and development of transformative...
12.02.2020
- Novo Nordisk has announced it will spend 800 million Danish Kroner (DKK, about $117.4 million) to further upgrade its insulin production site at Kalundborg, Denmark. The site’s...
29.01.2020
- Anglo-Swedish drugmaker AstraZeneca plans to invest up to $1 billion in a scheme it calls Ambition Zero Carbon, which as the name suggests is aimed at achieving zero carbon...
